Tamas is a medical doctor and economist by primary training. He also holds an MSc in Health Economics and in Pharmaceutical Medicine and a PhD. Over the course of 20 years, he has held various leadership positions at Pfizer, where he currently leads the company’s “Accord for a Healthier World” medical program.
https://medicalaffairs.org/wp-content/uploads/2024/05/Tamas-EMEA-elected-featured.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2024-05-29 13:05:012024-06-28 07:22:46MAPS Elects Tamas Andras Koncz, MD, PhD as EMEA Region President
MAPS is excited to announce publication of the MAPS Medical Affairs Competency Framework, detailing 42 competencies across 7 domains identified as essential to the success of Medical Affairs professionals.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
https://medicalaffairs.org/wp-content/uploads/2023/11/Charlotte-CMO-featured-2.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2023-11-03 10:23:152023-12-07 18:36:52MAPS Appoints Charlotte Kremer, MD, MBA, as Chief Medical Officer
Kesselring will work with the MAPS Professional Development Committee to assist with the creation of courses supporting 7 Medical Affairs competency certification tracks identified in the MAPS 5-year strategic plan.
https://medicalaffairs.org/wp-content/uploads/2023/10/Gustavo-Kesselring-Announcement.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2023-10-19 14:38:512023-12-08 08:11:32MAPS Appoints Dr. Gustavo Kesselring as Senior Advisor for Professional Development
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
https://medicalaffairs.org/wp-content/uploads/2023/04/Danie-du-Plessis-Board-Chair-Featured.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2023-04-11 11:46:272023-04-11 12:12:58Dr. Danie du Plessis Elected Chair of MAPS Board of Directors
From space biology to patient voice to best practices for onboarding, here are highlights of the APPA/MAPS Joint Medical Affairs Summit in Sydney, Australia.
https://medicalaffairs.org/wp-content/uploads/2022/12/Screenshot-2022-12-15-at-9.10.18-AM-1.png9942182Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2022-12-15 09:26:552022-12-15 09:28:14Highlights from the APPA/MAPS Joint Medical Affairs Summit 2022
At the MAPS 2022 Global Annual Meeting in New Orleans, we sat down with Medical Affairs leaders in attendance to discuss a range of issues important to the function. Now as we prepare for the MAPS 2023 Global Annual Meeting in Nashville, March 26-29 (early bird registration open until December 31!), join us in looking back at these important opinions. Have a topic you’d like covered at the 2023 meeting? Email MAPS Communications/Marketing Director, Garth Sundem, with your suggestions!
https://medicalaffairs.org/wp-content/uploads/2022/04/Monica-de-Abadal-Medical-Affairs-Table-Talk-Episode-07-WordPress-Image-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2022-12-07 14:59:172023-04-12 12:46:23Medical Affairs Leadership Interviews from the MAPS 2022 Global Annual Meeting
The Medical Affairs Professional Society (MAPS) is honored to announce the appointment of Charlotte Kremer, MD, MBA as the organization’s Chief Strategy Officer in a volunteer capacity, next to her volunteer role as Chair of the Board of Directors.
The Medical Affairs Professional Society (MAPS) and the Industry Pharmacists Organization (IPhO) are pleased to announce an important new strategic collaboration to help advance the careers of student pharmacists interested in the pharmaceutical industry, as well as Fellows and early-stage Industry Pharmacist professionals.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.